Diving Deep into HBOT: A Promising Treatment for Long COVID

Jul 19, 2023

Understanding Long COVID: Symptoms, Challenges, and Treatment Options

Long COVID has emerged as a significant concern for individuals who have recovered from acute COVID-19 infections. While many people experience a complete recovery, others continue to battle persistent symptoms and complications. This condition, also known as long COVID or post-acute sequelae of SARS-CoV-2, can have a profound impact on patient’s lives, requiring comprehensive management and treatment strategies.

Long COVID is characterised by a range of symptoms that persist for an extended period, typically more than 12 weeks after the initial infection. Common symptoms include persistent fatigue, respiratory issues, cognitive impairment (often referred to as “brain fog”), anxiety, and depression. It affects a diverse range of individuals, irrespective of age or prior health conditions, making it crucial to identify effective treatment options.

The Potential of Hyperbaric Oxygen Therapy (HBOT) in Long COVID Treatment

One promising treatment approach gaining attention in the medical community is Hyperbaric Oxygen Therapy (HBOT). HBOT involves breathing pure oxygen in a pressurised chamber, allowing the body to absorb higher levels of oxygen than it would under normal conditions. This therapy has shown promise in treating various conditions by promoting healing, reducing inflammation, and improving overall well-being.

Researchers are investigating the potential of HBOT as a treatment for long COVID. Preliminary studies have demonstrated positive outcomes, indicating that the therapy may help alleviate persistent symptoms and enhance the recovery process. HBOT has the potential to address issues such as lung damage, cognitive impairment, and fatigue, which are commonly associated with long COVID.

How Does HBOT Work in the Context of Long COVID?

Hyperbaric Oxygen Therapy functions by increasing oxygen levels in the body, which has several beneficial effects. First, it enhances the oxygen supply to damaged tissues, promoting healing and regeneration. Additionally, HBOT reduces inflammation and stimulates the production of growth factors that aid in tissue repair.

In the case of long COVID, HBOT may target the underlying factors contributing to persistent symptoms. By improving oxygenation in the lungs, it could mitigate lung damage caused by the initial infection. Furthermore, increased oxygen delivery to the brain may help alleviate cognitive impairments and “brain fog” experienced by long COVID patients.

Research and Studies on HBOT for Long COVID

A major study published in Nature Communications highlighted the potential benefits of HBOT in reducing lung tissue damage and improving respiratory function in pre-clinical models.

Clinical trials are underway to further explore the efficacy of HBOT in long COVID treatment. Researchers are examining the therapy’s impact on long-term symptoms, including fatigue, cognitive impairment, and mental health challenges. These studies aim to provide a deeper understanding of HBOT’s mechanisms and its potential to improve the quality of life for long COVID patients.

3 Benefits of Hyperbaric Oxygen Treatment for Long COVID Patients

Hyperbaric Oxygen Therapy offers several potential benefits for individuals grappling with long COVID. By addressing the underlying damage caused by the virus and promoting healing, HBOT may alleviate persistent symptoms and enhance the recovery process. Some of the key benefits include:

1. Improved lung function

HBOT helps mitigate lung damage, allowing patients to breathe more easily and reducing respiratory issues.

2. Enhanced cognitive function

Increased oxygen delivery to the brain may alleviate cognitive impairments, such as memory problems and difficulty concentrating.

3. Reduced fatigue

HBOT has the potential to alleviate persistent fatigue, allowing patients to regain energy and improve their overall well-being.

The Future of HBOT in Treatment for Long COVID 

As research on HBOT for long COVID progresses, healthcare providers and researchers are hopeful about its potential as a treatment option. Collaborative efforts between medical professionals, scientists, and patients are crucial to advancing our understanding of long COVID and identifying effective therapies.

In conclusion, Hyperbaric Oxygen Therapy shows promise as a treatment modality for long COVID, offering potential benefits in mitigating symptoms and promoting recovery. As the scientific community continues to delve into the mechanisms and efficacy of HBOT, it is essential for individuals experiencing long COVID to engage with healthcare professionals and explore comprehensive treatment options that suit their specific needs.

Contact our expert team of professionals at Better for a free consultation and discover how pure oxygen can support your treatment for long COVID.

 

Treatment for Long COVID: FAQs

What is long COVID, and how is it different from COVID-19?

Long COVID, also known as post-acute sequelae of SARS-CoV-2 or post-COVID-19 syndrome, refers to a condition where individuals experience persistent symptoms and complications after recovering from an acute COVID-19 infection. It is different from COVID-19, which is the initial viral infection caused by the SARS-CoV-2 virus. While COVID-19 typically lasts for a few weeks, long COVID symptoms can persist for an extended period, often more than 12 weeks.

How does Hyperbaric Oxygen Therapy (HBOT) work in treating long COVID?

Hyperbaric Oxygen Therapy (HBOT) involves breathing pure oxygen in a pressurised chamber, allowing the body to absorb higher levels of oxygen. In the context of long COVID, HBOT works by increasing oxygen levels in the body, promoting healing, reducing inflammation, and improving overall well-being. It may target lung damage, cognitive impairments, fatigue, and other persistent symptoms associated with long COVID.

How many HBOT sessions are typically needed for long COVID treatment?

The number of HBOT sessions needed for long COVID treatment can vary depending on individual circumstances and the severity of symptoms. Typically, a series of multiple sessions is recommended, ranging from several weeks to a few months. The specific treatment protocol and session frequency should be determined in consultation with healthcare professionals experienced in administering HBOT.

Are there any age or health restrictions for HBOT in long COVID patients?

Age and health restrictions for Hyperbaric Oxygen Therapy in long COVID patients can vary based on individual health conditions and the assessment of healthcare professionals. Generally, HBOT is considered safe for a wide range of individuals, including children and older adults. However, certain medical conditions, such as certain lung or heart conditions, may require additional evaluation and precautions before initiating HBOT. It is important to consult with a qualified healthcare provider to assess suitability for HBOT.

Is HBOT covered by insurance for long COVID treatment?

 Insurance coverage for HBOT in the context of long COVID can vary depending on the insurance provider and the specific policy. Some insurance plans may cover HBOT for certain medical conditions, while others may require pre-authorisation or have specific limitations. It is recommended to contact the insurance provider directly to inquire about coverage for HBOT in long COVID treatment and understand any requirements or restrictions that may apply.

Can HBOT help with mental health challenges associated with long COVID?

While HBOT primarily focuses on physical symptoms and promoting healing, some individuals with long COVID may experience mental health challenges such as anxiety, depression, or cognitive impairments. HBOT’s potential benefits on oxygenation and overall well-being may indirectly contribute to improved mental health. However, specific mental health challenges should be addressed through comprehensive treatment plans, including therapy, counselling, and appropriate mental health support in conjunction with HBOT.

Can long COVID patients experience reinfection after undergoing HBOT?

Long COVID patients who have recovered from their initial infection and undergone HBOT are not immune to reinfection with the SARS-CoV-2 virus. Long COVID is primarily a continuation of symptoms and complications from the initial infection rather than a new infection. It is important for long COVID patients to continue following preventive measures, such as vaccination, mask-wearing, and adhering to public health guidelines to reduce the risk of reinfection and further complications.